Chou Judy serves as Executive at Akero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Chou Judy has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 9, 2025 involved selling 9,398 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | AKRO | $0 | Disposition | 9,398 | $N/A | Discretionary |
Chou Judy currently holds 0 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chou Judy has been a net neutral trader of AKRO stock. They have purchased $0 and sold $0 worth of shares.
Chou Judy's most recent insider trade was on Dec 9, 2025, when they sold 9,398 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted